CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Eligibility and safety of sofosbuvir in a real-world single center cohort of patients with advanced cirrhosis, including decompensated cirrhosis
DOI 10.1055/s-0034-1397097
Bibliografische Angaben
Nachweis in CareLit
Autor:innenHzS Christoph, K Deterding, K Port, B Maasoumy, MP Manns, W Heiner, M Cornberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: With the approval of sofosbuvir (SOF) effective treatment with and without interferon has become available. We aim to assess the eligibility and safety of a SOF based therapy in patients (pts) with primarily advanced liver cirrhosis, including decompensated cirrhosis, in a real world setting. Methods: 207 patients have been evaluated in our outpatient clinic since the approval of SOF in January 2014. Rea…
Zitieren
Zitierempfehlung
HzS Christoph, K Deterding, K Port, B Maasoumy, MP Manns, W Heiner, M Cornberg (2015) Eligibility and safety of sofosbuvir in a real-world single center cohort of patients with advanced cirrhosis, including decompensated cirrhosis. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0034-1397097
Mit CareLit weiterarbeiten